Periprocedural management of patients on anticoagulants and antiplatelet agents undergoing cardiac implantable electronic device implantation
Keyword(s):
Almost half of patients who underwent CIED implantation receive antiplatelet or anticoagulant agents. Despite the number of trials, also randomized perioperative management with antiplatelet/anticoagulant therapy differs between centers. Some of physicians withdraw antiplatelet or anticoagulant therapy because of risk of pocket haematoma that could lead to reintervention, while some of them continue antiplatelet/anticoagulant therapy without concerns or put patient on the bridging therapy with LMWH. This article is an attempt to summarize reports and recommendations concerning problem of antiplatelet and antitrombotic therapy in periprocedural CIED period.
2021 ◽
2015 ◽
Vol 26
(4)
◽
pp. 312-319
◽
2020 ◽
Vol 6
(6)
◽
pp. 661-671
◽